The Role of Microorganisms in Causing Cystic Fibrosis

Le résumé fourni par la source

Cystic fibrosis (CF) is a complex genetic disorder characterized by impaired respiratory and digestive functions. While CF is primarily associated with mutations in the CFTR gene , recent research has highlighted the significant role of microorganisms in the pathogenesis of this disease. Microbial colonization of the airways in individuals with CF begins early in life, creating a unique pulmonary microenvironment characterized by chronic inflammation and altered mucus production. Pseudomonas aeruginosa , Staphylococcus aureus , and Burkholderia cepacia complex are among the key pathogens identified in CF airways, with their persistence and adaptation contributing to disease severity. Furthermore, recent studies have unveiled the dynamic interplay between the host immune response and microbial communities, influencing the clinical course of CF. Understanding the intricate relationships between microorganisms and CF is crucial for developing targeted therapeutic interventions. Emerging research on microbiome modulation, antimicrobial strategies, and personalized treatment approaches holds promise for improving the management and outcomes of individuals affected by CF. This chapter consolidates current knowledge on the role of microorganisms in CF, shedding light on potential avenues for future research and therapeutic innovations.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.